Holds one active US DMF for iopromide, filing since 1989. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 46 markets.
Holds one active US DMF for iopromide, filing since 1989. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 46 markets.
Holds 2 valid CEPs for iopromide, filing since 2022. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 22 markets.
Holds one valid CEP for iopromide, filing since 2025. Its 2024 FDA inspection closed as NAI.
Holds one active US DMF for iopromide, filing since 2020.
Holds one active US DMF for iopromide, filing since 2025.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for iopromide and what filings they hold.
Chat with Fred, your AI analyst